Provided by Tiger Fintech (Singapore) Pte. Ltd.

CANBRIDGE-B

2.220
+0.0200.91%
Volume:320.00K
Turnover:702.97K
Market Cap:1.13B
PE:-1.95
High:2.270
Open:2.150
Low:2.150
Close:2.200
52wk High:3.100
52wk Low:0.095
Shares:511.00M
HK Float Shares:511.00M
Volume Ratio:0.35
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.137
ROE:-281.91%
ROA:-57.53%
PB:-2.54
PE(LYR):-1.95
PS:16.62

Loading ...

Hong Kong Stocks Movement | CANBRIDGE-B (01228) Surges Over 12% Again on Strategic Investment from Qingdao Baheal Medical and Three Products Clear Initial Review for Commercial Insurance Innovation Drug Directory

Stock News
·
Aug 25

Hong Kong Stocks Alert | CANBRIDGE-B (01228) Surges Nearly 17% Again, Accumulating Over 15-Fold Gain This Year Following Strategic Investment from Baheal Medical

Stock News
·
Aug 22

Hong Kong Stock Movement | CANBRIDGE-B (01228) Surges Nearly 9% Again as Three Rare Disease Products Pass Formal Review for Commercial Insurance Innovative Drug Directory

Stock News
·
Aug 19

HK Movers | HK's Biotech Shares Soar. CANbridge up 29%; Ab&B Bio-Tech up 26%; Abbisko up 7%

Tiger Newspress
·
Aug 13

BRIEF-Canbridge Pharmaceuticals Announces Units Formalized Strategic Relationship

Reuters
·
Aug 12

BRIEF-CANbridge Pharmaceuticals Inc To Issue 75 Million Subscription Shares At HK$1.34 Per Share

Reuters
·
Aug 12

CANbridge Pharmaceuticals Inc - to Issue 75 Mln Subscription Shares at HK$1.34 per Share

THOMSON REUTERS
·
Aug 12

CANbridge Pharmaceuticals Inc - 2 Units Formalized Strategic Relationship With Unit of Qingdao Baheal Medical

THOMSON REUTERS
·
Aug 12

CANbridge Pharmaceuticals - Qingdao Baheal Medical Appointed Exclusive Contract Sales Organization for Co in China, HK, Macau

THOMSON REUTERS
·
Aug 12

HKEX - Trading in Shares of CANbridge Pharmaceuticals Inc. Will Be Halted at 9:00 a.m. Today

THOMSON REUTERS
·
Aug 12

HK Movers | HK's Biotech Shares Soar. CANbridge up 20%; Boan Biotech up 16%; Hengrui Pharma up 8%

Tiger Newspress
·
Jul 14

Canbridge Pharmaceuticals Relocates Hong Kong Office to Dah Sing Financial Centre

Reuters
·
Jul 11

CANbridge Pharmaceuticals Inc. Announces Appointment of Zhao Wei as Non-Executive Director and Board Committee Changes

Reuters
·
Jul 01

Canbridge Pharmaceuticals Inc. Conducted Annual General Meeting

Reuters
·
Jun 27

Canbridge Pharmaceuticals Announces Resignation of Non-Executive Director and Board Committee Changes

Reuters
·
Jun 25

HK Movers | HK's Biotech Shares Soar. JOINN Soars 8%; Fudan-Zhangjiang up 6%; HeartCare up 2%

Tiger Newspress
·
Jun 17

CANbridge Pharmaceuticals Gets China Nod to Marketing Gaucher Disease Drug

MT Newswires Live
·
May 20

BRIEF-Canbridge Pharmaceuticals Says Velaglucerase-Beta Injection Approved In China

Reuters
·
May 20

CANbridge Pharmaceuticals Inc. Secures Marketing Approval for Velaglucerase-beta (Gaurunning, CAN103) in China for Gaucher Disease Treatment

Reuters
·
May 20